Author: Walker Michael A
Publisher: Informa Healthcare
ISSN: 1354-3776
Source: Expert Opinion on Therapeutic Patents, Vol.16, Iss.3, 2006-03, pp. : 249-264
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
This review covers patent literature for new targets, biomarkers and potential drugs for the treatment of autism and related pervasive developmental disorders, for patent applications published between 2000 and mid-year 2005. Recent studies into the underlying genetic aetiology of autism has resulted in a number of potential targets for drug development. Less research is being carried out in the clinical examination of agents specifically designed to treat autism. Nonetheless, promising leads in target and drug discovery have been discovered over the course of the time period examined.
Related content
No link between MMR vaccine and pervasive developmental disorders
Reactions Weekly, Vol. 1, Iss. 1019, 2004-01 ,pp. :